Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab Maintenance after Platinum-based Chemotherapy in NSCLC Patients Following TKI Therapy Failure
KCT0004541Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- May 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nivolumab in non-small cell lung cancer (NSCLC), sponsored by Ono Pharmaceutical. Started May 2020; status: completed.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on KCT0004541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004541.